Insider: Shawver Laura Director - ARS Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 210,346 | 0 | 210,346 |
| Value | $1,705,906.06 | $0.00 | $1,705,906.06 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 04/07/2025 | DDS | 50,002 | Direct | COM | $12.30 | $615,074.60 | 210,346 |
| 03/06/2025 | DDS | 49,600 | Direct | COM | $11.21 | $556,045.76 | 210,346 |
| 03/05/2025 | DDS | 400 | Direct | COM | $11.00 | $4,400.00 | 210,346 |
| 02/03/2025 | DDS | 50,000 | Direct | COM | $12.31 | $615,565.00 | 210,346 |
| 12/04/2024 | DDS | 14,772 | Direct | COM | $13.75 | $203,109.09 | 210,346 |
| 12/03/2024 | DDS | 87,984 | Direct | COM | $13.26 | $1,166,896.60 | 210,346 |
| 12/02/2024 | DDS | 96,343 | Direct | COM | $13.55 | $1,305,823.39 | 211,247 |
| 12/02/2024 | DDS | 901 | Direct | COM | $14.34 | $12,921.87 | 210,346 |
| 09/01/2023 | DDS | 100,000 | Direct | COM | $7.71 | $770,520.00 | 210,346 |
| 08/04/2023 | DDS | 18,897 | Direct | COM | $7.06 | $133,471.40 | 210,346 |
| 08/03/2023 | DDS | 26,107 | Direct | COM | $7.01 | $183,017.90 | 210,346 |
| 08/02/2023 | DDS | 36,281 | Direct | COM | $7.09 | $257,264.94 | 210,346 |
| 08/01/2023 | DDS | 18,715 | Direct | COM | $7.19 | $134,575.82 | 210,346 |
| 07/07/2023 | DDS | 8,858 | Direct | COM | $6.36 | $56,372.31 | 210,346 |
| 06/02/2023 | DDS | 26,941 | Direct | COM | $6.95 | $187,239.95 | 210,346 |
| 06/01/2023 | DDS | 73,059 | Direct | COM | $6.80 | $496,801.20 | 210,346 |
| 05/09/2023 | DDS | 42,900 | Direct | COM | $5.31 | $227,799.00 | 210,346 |
| 05/08/2023 | DDS | 57,100 | Direct | COM | $6.16 | $351,736.00 | 210,346 |
| 11/09/2022 | DDS | 43,896 | Direct | COM | $4.58 | $201,043.68 | 210,346 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research